# Correction: Sumarni et al. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. Cells 2021, 10, 987

**Authors:** Uly Sumarni, Ulrich Reidel, Jürgen Eberle

PMC · DOI: 10.3390/cells14070535 · Cells · 2025-04-03

## Full-text entities

- **Genes:** PRKCD (protein kinase C delta) [NCBI Gene 5580] {aka ALPS3, CVID9, MAY1, PKCD, nPKC-delta}, CFLAR (CASP8 and FADD like apoptosis regulator) [NCBI Gene 8837] {aka CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1}, XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331] {aka API3, BIRC4, IAP-3, ILP1, MIHA, XLP2}
- **Diseases:** Cutaneous T-Cell Lymphoma (MESH:D016410)
- **Chemicals:** ROS (-), Ingenol Mebutate (MESH:C486592)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11988914/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11988914/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11988914/full.md

---
Source: https://tomesphere.com/paper/PMC11988914